Literature DB >> 19500931

Analysis of perfusion weighted image of CNS lymphoma.

In Ho Lee1, Sung Tae Kim, Hyung-Jin Kim, Keon Ha Kim, Pyoung Jeon, Hong Sik Byun.   

Abstract

PURPOSE: It is difficult to differentiate CNS lymphoma from other tumors such as malignant gliomas, metastases, or meningiomas with conventional MR imaging, because the imaging findings are overlapped between these tumors. The purpose of this study is to investigate the perfusion weighted MR imaging findings of CNS lymphomas and to compare the relative cerebral blood volume ratios between CNS lymphomas and other tumors such as high grade gliomas, metastases, or meningiomas.
MATERIALS AND METHODS: We retrospectively reviewed MRI findings and clinical records in 13 patients with pathologically proven CNS lymphoma between January 2006 and November 2008. We evaluated the relative cerebral blood volume ratios of tumor, which were obtained by dividing the values obtained from the normal white matter on MRI.
RESULTS: Total 13 patients (M:F=8:5; age range 46-67 years, mean age 52.3 years) were included. The CNS lymphomas showed relatively low values of maximum relative CBV ratio in most patients regardless of primary or secondary CNS lymphoma.
CONCLUSION: Perfusion weighted image may be helpful in the diagnosis of CNS lymphoma in spite of primary or secondary or B cell or T cell.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500931     DOI: 10.1016/j.ejrad.2009.05.013

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  20 in total

1.  Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Z Xing; R X You; J Li; Y Liu; D R Cao
Journal:  Clin Neuroradiol       Date:  2013-08-31       Impact factor: 3.649

2.  Dural-based lesions: is it a meningioma?

Authors:  Vitor Nagai Yamaki; Luis Filipe de Souza Godoy; Gabriela Alencar Bandeira; Leandro Tavares Lucato; Gustavo Correa Lordelo; Davi Jorge Fontoura Solla; Iuri Santana Neville; Manoel Jacobsen Teixeira; Wellingson Silva Paiva
Journal:  Neuroradiology       Date:  2021-01-18       Impact factor: 2.804

Review 3.  Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.

Authors:  A Romano; M C Rossi Espagnet; L F Calabria; V Coppola; L Figà Talamanca; V Cipriani; G Minniti; A Pierallini; L M Fantozzi; A Bozzao
Journal:  Radiol Med       Date:  2011-09-02       Impact factor: 3.469

4.  Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI.

Authors:  A Pons-Escoda; A Garcia-Ruiz; P Naval-Baudin; M Cos; N Vidal; G Plans; J Bruna; R Perez-Lopez; C Majos
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

5.  Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.

Authors:  S Wang; S Kim; S Chawla; R L Wolf; D E Knipp; A Vossough; D M O'Rourke; K D Judy; H Poptani; E R Melhem
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

6.  Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.

Authors:  Koung Mi Kang; Seung Hong Choi; Park Chul-Kee; Tae Min Kim; Sung-Hye Park; Joo Ho Lee; Soon-Tae Lee; Inpyeong Hwang; Roh-Eul Yoo; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

7.  Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yoshimoto; Satoshi O Suzuki; Koichiro Abe; Kazufumi Kikuchi; Yasuhiro Maruoka; Masahiro Mizoguchi; Toru Iwaki; Hiroshi Honda
Journal:  Neuroradiology       Date:  2012-09-09       Impact factor: 2.804

8.  Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.

Authors:  C H Toh; K-C Wei; C-N Chang; S-H Ng; H-F Wong
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

9.  Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL.

Authors:  Brian T Farrell; Bronwyn E Hamilton; Edit Dósa; Endre Rimely; Morad Nasseri; Seymur Gahramanov; Cynthia A Lacy; Eugene P Frenkel; Nancy D Doolittle; Paula M Jacobs; Edward A Neuwelt
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

10.  MR perfusion in and around the contrast-enhancement of primary CNS lymphomas.

Authors:  Stella Blasel; Alina Jurcoane; Oliver Bähr; Lutz Weise; Patrick N Harter; Elke Hattingen
Journal:  J Neurooncol       Date:  2013-05-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.